Neuriva Brain Pill $8 Million Class Settlement Contested Again

An $8 million false ad class deal between Neuriva memory supplement consumers and Reckitt Benckiser LLC faces another challenge, as an objector is appealing the settlement’s approval to the Eleventh Circuit.

David Williams and others alleged Reckitt Benckiser and RB Health (US) LLC deceptively touted the brain booster as “backed by science” and “clinically proven” to improve brain performance when there is no scientific or clinical proof it provides any such benefit.

The deal provides $8 million to pay claims as they’re made, allowing up to $65 each for class members with proof of purchase, and up to $20 for ...